Dr. Anna Falk

Head Of Product at Harmony

Dr. Anna Falk has a diverse and extensive work experience. Dr. Anna started their career as a Visiting PhD Student at UC Berkeley in 2013. In 2015, they worked as a Postdoctoral Researcher at The University of Edinburgh. Following that, they co-founded Ardeus in 2016, where they held the roles of Co-Founder, Product Management, and R&D until 2017. From 2017 to 2018, they worked as an Analytical Officer at The University of Edinburgh. In 2018, they joined Harmony as a Product Manager and later became the Head of Product in 2019. Throughout their career, they have accomplished various research objectives, published results in peer-reviewed journals, and presented at conferences. Dr. Anna holds a PhD in Chemistry from the University of Cologne, where they were a PhD student from 2011 to 2014, with a focus on Nickel-catalysed hydrocyanation and natural product total synthesis.

Dr. Anna Falk holds a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry, which they obtained from the University of Cologne from 2011 to 2014. Dr. Anna also completed a Diploma in Chemistry at the same university from 2006 to 2011. In 2013, they had a brief stint at the University of California, Berkeley, where they focused on Organic Chemistry. After completing their doctoral studies, Dr. Falk pursued a postdoctoral position in Molecular Weight Enhanced Metathesis Catalysts at The University of Edinburgh. Apart from their academic achievements, they obtained a Sports Nutritionist Certification from the International Sports Sciences Association (ISSA) in January 2022.

Location

Barcelona, Spain

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Harmony

Harmony is a pioneer in hemp, crafting innovative CBD products to bring the full potential of cannabinoids all over the world. Along with his team, CEO/founder Antonin Cohen developed Harmony after realizing the urgent need to expand access to qualitative cannabinoids.


Industries

Employees

11-50

Links